'I never heard of the Strait of Hormuz before this': How one CEO is navigating the oil price shock

2 days ago

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

6 days ago

Cavs owner Dan Gilbert turns grief over son's rare disease into search for cure

6 days ago

Eli Lilly accuses church bishops, businessmen of fraud in drug rebate scheme

6 days ago

Trump says he's 'concerned' about Ebola after American tests positive in Africa

8 days ago

White House adds generic drugs to direct-to-consumer TrumpRx site

8 days ago

CDC says American tests positive for Ebola in Africa, risk in U.S. remains low

8 days ago

FDA shuffles top drug, biologics leaders in latest leadership shakeup

11 days ago

Bristol Myers Squibb turns to China to develop new drugs

11 days ago

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

12 days ago

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

12 days ago

Hantavirus isn't another Covid, but experts say it's testing U.S. readiness

12 days ago

Trump says Makary resigns as FDA commissioner following backlash

12 days ago

Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients

14 days ago

Jim Cramer says today's market is punishing stocks harder than 1999

15 days ago

Hantavirus cases spark brief surge in pharma and biotech stocks — here's why trading is so volatile

15 days ago

Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk

15 days ago

Fitness wearable Whoop to offer on-demand clinician access to U.S. users

18 days ago

Healthy Returns: Novo Nordisk faces Ozempic generics in Canada

18 days ago

Planet Fitness stock plunges 30% after company slashes guidance

19 days ago

Family office deal-making rebounds in April with healthcare bets

19 days ago

Rare disease families find roadmap to drug development at bootcamps

20 days ago

Novo Nordisk CEO says the drugmaker is more active than ever for dealmaking

20 days ago

Wearable patches: How Barrière is trying to disrupt the supplement industry

20 days ago

CVS blows past estimates, hikes outlook as insurance business outperforms

21 days ago

FDA withdrew studies finding Covid and shingles vaccines were safe

20 days ago

FDA commissioner defends agency's drug approval decisions after wave of backlash

21 days ago

Major health insurers show early strength – but a key test looms in Q2

21 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

22 days ago

Novo's head start on GLP-1 pills forces investors to rethink Lilly's dominance

22 days ago

Weight loss and hair loss: The growing hair treatment market from GLP-1s

24 days ago

Cardinal Health's sell-off on earnings was an overreaction. We'd be buyers

25 days ago